Cite
APA Citation
McCurdy, S., Nenninger, A., Sheets, A., Keedy, K., Lawrence, L., Quintas, M., & Cammarata, S. (2020). efficacy of delafloxacin versus moxifloxacin against atypical bacterial respiratory pathogens in adults with community-acquired bacterial pneumonia (CABP): Data from the Delafloxacin Phase 3 CABP Trial. International journal of infectious diseases, 97, 374–379. http://access.bl.uk/ark:/81055/vdc_100105279736.0x00001e